Announce Date | 04/17/2025 |
EPS Normalized Actual | $0.58 (Beat by $0.15) |
EPS GAAP Actual | $0.58 (Beat by $0.15) |
Revenue Actual | $3.456B |
Revenue Surprise | Beat by $3456M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.21917 |
EPS GAAP Estimate | $1.21917 |
Revenue Estimate | $2.293406857B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 5.7 | 7.23 | 5.31946 | 6.09492 | 5 |
Dec 2026 | 6.66268 | 6.19 | 6.42285 | 6.91157 | 9 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.82 | -0.82 | 3.456B | -18.98% | 3456M |
FQ2 2002 (Jun 2002) | 0 | 0 | 3.673B | 100% | 3673M |
FQ4 2024 (Dec 2024) | 0 | 0 | 2.24B | 100% | 2240M |
FQ3 2024 (Sep 2024) | 1.07 | 1.07 | 4.189B | 47.96% | 4189M |
FQ2 2024 (Jun 2024) | 0.96 | 0.96 | 4.043B | 43.63% | 4043M |
FQ1 2024 (Mar 2024) | 0.51 | 0.51 | 4.112B | 43.43% | 4112M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | -INF% | 0M |
FQ3 2023 (Sep 2023) | 0.88 | 0.88 | 2.18B | 73.44% | 2180M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.21917
Consensus Revenue Estimates
2.293406857B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.4921 | -- | 1.42089 | 1.56597 | 8 |
FQ3 2027 (Sep 2027) | 1.5874 | -- | 1.51164 | 1.66599 | 8 |
FQ2 2027 (Jun 2027) | 1.3582 | -- | 1.29338 | 1.42544 | 8 |
FQ1 2027 (Mar 2027) | 1.2704 | -- | 1.20977 | 1.3333 | 8 |
FQ4 2026 (Oct 2026) | 1.56787 | -- | 1.53683 | 1.60339 | 9 |
FQ3 2026 (Jul 2026) | 1.46403 | -- | 1.43505 | 1.49719 | 9 |
FQ2 2026 (Jun 2026) | 1.95 | -- | 1.89678 | 2.00094 | 9 |
FQ1 2026 (Mar 2026) | 2.4 | 134.17 | 2.3345 | 2.46269 | 9 |
FQ4 2025 (Oct 2025) | 1.43833 | -- | 1.40985 | 1.47091 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.19B | -- | 3.08B | 3.31B | 6 |
FQ3 2027 (Sep 2027) | 3.11B | -- | 3B | 3.23B | 3 |
FQ2 2027 (Jun 2027) | 3.03B | -- | 2.92B | 3.15B | 3 |
FQ1 2027 (Mar 2027) | 2.96B | -- | 2.85B | 3.07B | 3 |
FQ4 2026 (Oct 2026) | 14.49B | -- | 14.27B | 14.74B | 5 |
FQ3 2026 (Jul 2026) | 14.62B | -- | 14.4B | 14.88B | 5 |
FQ2 2026 (Jun 2026) | 2.7B | -- | 2.65B | 2.76B | 5 |
FQ1 2026 (Mar 2026) | 2.69B | -28.62 | 2.63B | 2.74B | 5 |
FQ4 2025 (Oct 2025) | 2.41B | 7.01 | 2.37B | 2.45B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
1
EPS # of in-lines
3
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.82 | -0.82 | 100% | |
FQ2 2002 (Jun 2002) | 0 | 0 | NAN% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 1.07 | 1.07 | 100% | |
FQ2 2024 (Jun 2024) | 0.96 | 0.96 | 100% | |
FQ1 2024 (Mar 2024) | 0.51 | 0.51 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0.88 | 0.88 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $3.46B | $3456M | 100% |
FQ2 2002 (Jun 2002) | $0B | $3.67B | $3673M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.24B | $2240M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.19B | $4189M | 100% |
FQ2 2024 (Jun 2024) | $0B | $4.04B | $4043M | 100% |
FQ1 2024 (Mar 2024) | $0B | $4.11B | $4112M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $2.18B | $2180M | 100% |